Damora Therapeutics, Inc.
DMRA
9 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Aug 6 3:34 PM | Firmani Lori | Proposed Sale | 1,800 | $31.10 | $56.0K | — | View → |
| Jul 6, 2026 | Jul 8 12:00 AM | Garrett WinslowGeneral Counsel | Sale | 245 | $29.98 | $7.3K | 2,289(D) | View → |
| Jun 22, 2026 | Jun 22 6:27 PM | Firmani Lori | Proposed Sale | 7,615 | $25.36 | $193.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 13 9:00 PM | Andrew ChengDirector | Grant/Award | 30,350 | $31.00 | 30,350(D) | View → |
| Jul 3, 2026 | Jul 8 12:00 AM | Garrett WinslowGeneral Counsel | Option Exercise | 680 | — | 640(D) | View → |
| Mar 30, 2026 | Apr 1 9:30 PM | Jennifer JarrettDirector, President and Chief Executive Officer | Grant/Award | 1,500,000 | $25.50 | 1,500,000(D) | View → |
| Mar 23, 2026 | Mar 25 10:09 PM | Garrett WinslowGeneral Counsel | Grant/Award | 250,000 | $23.05 | 250,000(D) | View → |
| Mar 23, 2026 | Mar 25 10:08 PM | Cameron TurtleDirector | Grant/Award | 37,313 | $23.05 | 37,313(D) | View → |
| Mar 23, 2026 | Mar 25 10:05 PM | Michael LandsittelDirector | Grant/Award | 37,313 | $23.05 | 37,313(D) | View → |
| Mar 23, 2026 | Mar 25 10:03 PM | Fairmount Funds Management LLCDirector, 10% Owner | Grant/Award | 37,313 | $23.05 | 37,313(I) | View → |
| Mar 23, 2026 | Mar 25 10:01 PM | Christopher W. CainDirector | Grant/Award | 37,313 | $23.05 | 37,313(D) | View → |
| Mar 23, 2026 | Mar 25 9:57 PM | Julianne BrunoDirector | Grant/Award | 37,313 | $23.05 | 37,313(D) | View → |
| Feb 9, 2026 | Feb 12 11:05 AM | Julianne BrunoDirector | Option Exercise | 129 | — | 0(D) | View → |
| Feb 9, 2026 | Feb 12 11:03 AM | Fairmount Funds Management LLCDirector, 10% Owner | Option Exercise | 8,713 | — | 574(I) | View → |
| Jan 5, 2026 | Jan 27 2:04 AM | Sherwin SattarzadehChief Operating Officer | Grant/Award | 444,209 | $21.82 | 444,209(D) | View → |